1
de Vries, F, Souverein, P C, Cooper, C, Leufkens, H G M, van Staa, T P
Veröffentlicht in: de Vries , F , Souverein , P C , Cooper , C , Leufkens , H G M & van Staa , T P 2007 , ' Use of beta-blockers and the risk of hip/femur fracture in the United Kingdom and The Netherlands ' , Calcified Tissue International , vol. 80 , no. 2 , pp. 69-75 . https://doi.org/10.1007/s00223-006-0213-1;
2007
Veröffentlicht in: de Vries , F , Souverein , P C , Cooper , C , Leufkens , H G M & van Staa , T P 2007 , ' Use of beta-blockers and the risk of hip/femur fracture in the United Kingdom and The Netherlands ' , Calcified Tissue International , vol. 80 , no. 2 , pp. 69-75 . https://doi.org/10.1007/s00223-006-0213-1;
2007
2
3
4
5
6
7
8
Arbouw, M E L, Movig, K L L, van Staa, T P, Egberts, A C G, Souverein, P C, de Vries, F
Veröffentlicht in: Arbouw , M E L , Movig , K L L , van Staa , T P , Egberts , A C G , Souverein , P C & de Vries , F 2011 , ' Dopaminergic drugs and the risk of hip or femur fracture : a population-based case-control study ' , Osteoporosis International , vol. 22 , no. 7 , pp. 2197-204 . https://doi.org/10.1007/s00198-010-1455-3;
2011
Veröffentlicht in: Arbouw , M E L , Movig , K L L , van Staa , T P , Egberts , A C G , Souverein , P C & de Vries , F 2011 , ' Dopaminergic drugs and the risk of hip or femur fracture : a population-based case-control study ' , Osteoporosis International , vol. 22 , no. 7 , pp. 2197-204 . https://doi.org/10.1007/s00198-010-1455-3;
2011
9
10
van den Bogert, C.A., Souverein, P.C., Brekelmans, C.T.M., Janssen, S.W.J., Koëter, G.H., Leufkens, H.G.M., Bouter, L.M.
Veröffentlicht in: van den Bogert , C A , Souverein , P C , Brekelmans , C T M , Janssen , S W J , Koëter , G H , Leufkens , H G M & Bouter , L M 2016 , ' Non-publication is common amomg phase 1, single-center, not prospectively registered, or early terminated clinical drug trials: results of a nationwide inception cohort study in the Netherlands ' , PLoS ONE . https://doi.org/10.1371/journal.pone.0167709;
2016
Veröffentlicht in: van den Bogert , C A , Souverein , P C , Brekelmans , C T M , Janssen , S W J , Koëter , G H , Leufkens , H G M & Bouter , L M 2016 , ' Non-publication is common amomg phase 1, single-center, not prospectively registered, or early terminated clinical drug trials: results of a nationwide inception cohort study in the Netherlands ' , PLoS ONE . https://doi.org/10.1371/journal.pone.0167709;
2016